Pharmaron   Report issue

For profit Phase 1 Phase 2
Founded: Beijing China (2004)

Organization Overview

First Clinical Trial
2018
NCT03565861
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Pharmaron | Pharmaron CPC | Pharmaron CPC, Inc.